Snapshot img

Radiation Therapy Equipment Market Size 2024-2028

The radiation therapy equipment market size is forecast to increase by USD 1.59 billion at a CAGR of 5.82% between 2023 and 2028.

The Radiation Oncology Market, encompassing Radiotherapy Devices and Radiation Detection and Monitoring Equipment, exhibits significant growth due to the increasing incidence of cancer, particularly colorectal cancer. This trend is further fueled by advancements in customer support services provided by market companies, ensuring optimal patient care. However, the high cost of radiation therapy equipment remains a challenge for market expansion, particularly in underserved regions. Market participants must innovate to offer cost-effective solutions without compromising quality to cater to a broader customer base. The Radiation Detection and Monitoring Equipment Market plays a crucial role in ensuring patient safety and treatment efficacy, making it an essential segment withIn the Radiation Oncology Market.

What will be the Size of the Radiation Therapy Equipment Market During the Forecast Period?

Request Free Sample

The market encompasses a diverse range of technologies and devices used in cancer treatment, including proton therapy, treatment planning systems, and various imaging modalities. The market is driven by the increasing incidence of cancer and the availability of advanced radiotherapy devices that offer improved accuracy and precision in tumor targeting. Radiotherapists and oncologists utilize imaging data for dose calculation and delivery techniques such as intensity-modulated radiotherapy (IMRT), stereotactic radiotherapy (Stereotactic), and the Radixact system. Technology trends include telemedicine, which enhances access to healthcare, and the integration of imaging techniques for better tumor visualization. Cancer types like breast cancer, skin cancer (including basal cell carcinoma, melanoma, and squamous cell carcinoma), and lip cancer continue to fuel market growth.
Market dynamics are influenced by ongoing research studies and the continuous development of advanced radiotherapy devices and treatment methods. company analysis indicates a competitive landscape with numerous players offering innovative solutions to meet the evolving needs of the healthcare industry.

How is this Radiation Therapy Equipment Industry segmented and which is the largest segment?

The radiation therapy equipment industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

End-user

  Hospitals
  Ambulatory surgical centers
  Oncological treatment centers


Product

  External beam radiation therapy device
  Internal beam radiation therapy device


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  Asia

    China


  Rest of World (ROW)

By End-user Insights

The hospitals segment is estimated to witness significant growth during the forecast period. Radiotherapy, a sophisticated treatment modality for various medical conditions, primarily cancer, necessitates advanced equipment and infrastructure. Hospitals, with their extensive resources, serve as the primary consumers of radiotherapy technology. Equipped with dedicated oncology departments or cancer centers, these healthcare facilities invest in radiotherapy devices for delivering precise radiation doses to cancerous tumors, minimizing damage to healthy tissues. Adoption of these devices offers numerous advantages, including enhanced precision, reduced side effects, improved patient outcomes, and increased treatment efficiency. Radiotherapy technology drives the delivery of complex procedures with heightened accuracy and safety. Proton therapy, treatment planning, imaging data, and cancer treatment are integral components of radiotherapy.

Technological advancements have led to the emergence of HDR brachytherapy, systemic radiotherapy, and various delivery techniques such as intensity-modulated radiotherapy and stereotactic radiotherapy. Imaging techniques, dose calculation, and delivery techniques play crucial roles in ensuring effective radiotherapy treatment. The prevalence of cancer and increasing access to healthcare in emerging economies fuel the demand for radiotherapy devices. company analysis, market facets, and upcoming trends shape the radiotherapy equipment market landscape.

Get a glance at the market report of various segments Request Free Sample

The Hospitals segment was valued at USD 2.21 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers t

The Radiotherapy Optimisation Test Set (TROTS) is an extensive set of problems originating from radiotherapy (radiation therapy) treatment planning. This dataset is created for 2 purposes: (1) to supply a large-scale dense dataset to measure performance and quality of mathematical solvers, and (2) to supply a dataset to investigate the multi-criteria optimisation and decision-making nature of the radiotherapy problem. The dataset contains 120 problems (patients), divided over 6 different treatment protocols/tumour types. Each problem contains numerical data, a configuration for the optimisation problem, and data required to visualise and interpret the results. The data is stored as HDF5 compatible Matlab files, and includes scripts to work with the dataset.

The set as present in this version is of date 13 May 2019. Updated versions of the Scripts and other extensions can be found at the following pages:

Persistent page with links: Erasmus University Rotterdam Library

Mirror project page: TROTS Mirror

Main publication: S. Breedveld & B. Heijmen, Data for TROTS - The Radiotherapy Optimisation Test Set, Data in Brief 12 (2017) 143-149

Overview

New York, NY – July 14, 2025: The Global Radiation Therapy Market is projected to grow from US$ 7.4 billion in 2023 to around US$ 13.4 billion by 2033. This reflects a CAGR of 6.1% during the forecast period from 2024 to 2033. Radiation therapy plays a vital role in cancer treatment and is used in nearly 50% of all cancer cases. It works by delivering high-energy radiation to kill cancer cells while protecting surrounding healthy tissues. As cancer rates continue to climb globally, the need for effective and accessible radiation treatment is becoming more urgent.

Developed nations are focusing on upgrading outdated equipment and expanding their cancer care infrastructure. Government investment in modern technologies, such as image-guided radiation therapy and proton therapy, is helping hospitals offer better treatment. These advanced systems reduce treatment time, limit side effects, and allow for more precise targeting of tumors. As a result, patient outcomes are improving and healthcare systems can serve more patients efficiently. This shift toward high-performance equipment is a key driver of market growth.

In contrast, many low- and middle-income countries struggle with limited access to radiation therapy. Barriers include a shortage of machines, trained professionals, and treatment centers. To address this gap, global organizations like the World Health Organization (WHO) and the International Atomic Energy Agency (IAEA) are leading support initiatives. These programs aim to improve infrastructure, train healthcare workers, and ensure that treatment facilities follow international standards. Bridging this gap is essential to ensure equitable cancer care worldwide.

Healthcare policy is also shaping the market. In several countries, value-based care models and bundled payments are being introduced to promote the use of advanced radiation therapies. These payment systems reward hospitals for delivering effective, cost-efficient treatment. As a result, more providers are adopting the latest technologies, which further boosts market growth. Policies that support reimbursement for newer treatments are proving critical in encouraging innovation and adoption.

Lastly, training and safety remain top priorities. Organizations such as the IAEA run training sessions and provide technical support to ensure safe, high-quality care. These efforts help build trust in radiation therapy systems and promote long-term investment. As technology evolves and global cooperation expands, radiation therapy is becoming more accurate, accessible, and effective. This progress is essential in the global fight against cancer and continues to create strong momentum for the market.

https://sp-ao.shortpixel.ai/client/to_auto,q_lossy,ret_img,w_1217,h_697/https://market.us/wp-content/uploads/2024/12/Radiation-Therapy-Market-Size.jpg" alt="Radiation Therapy Market Size" class="wp-image-136505">

Introduction

Global Radiation Oncology Market size is expected to be worth around USD 19.2 Billion by 2032 from USD 8.9 Billion in 2023, growing at a CAGR of 9.1% during the forecast period from 2024 to 2032.

The global radiation oncology market is experiencing significant growth driven by the increasing prevalence of cancer worldwide, influenced by aging populations, lifestyle changes, and environmental factors. Radiotherapy plays a crucial role in cancer treatment, with nearly 50% of patients undergoing it as part of their treatment regimen, and it contributes to 40% of curative treatments. The therapeutic benefits of radiotherapy, coupled with technological advancements such as intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), and proton therapy, have greatly improved treatment precision and patient outcomes.

Additionally, the integration of radiation therapy with chemotherapy and surgery in combination therapies has broadened treatment options, enhancing the efficacy of cancer care. The demand for radiation therapy products is further fueled by rising government spending on healthcare and the opportunities emerging from developing economies.

According to the World Health Organization, the most prevalent cancers in 2020 included breast, lung, and colorectal, with respective case counts of 2.26 million, 2.21 million, and 1.93 million. The American Cancer Society estimates around 1.9 million new cancer diagnoses in the U.S. for 2022. Furthermore, the Global Cancer Observatory reported significant regional disparities in cancer incidence for 2022, with Asia accounting for 49.2% of cases, followed by Europe at 22.4%, Latin America at 13.4%, the Caribbean at 7.8%, and other regions comprising 7.2%.

https://market.us/wp-content/uploads/2023/05/Radiation-Oncology-Market.jpg" alt="Radiation Oncology Market" class="wp-image-101804">

In 2021, the number of radiation therapy units in Germany remained nearly unchanged at around 398 units. However, 2021 marked the second consecutive increase of the number of radiation therapy units. Radiation therapy equipment describes machines used for treatment with x-rays or radionuclide. By and large, this includes linear accelerators, Cobalt-60 units, Caesium-137 therapy units, low to orthovoltage x-ray units, high dose and low dose rate brachytherapy units and conventional brachytherapy units. Radiation therapy (or radiotherapy) is mostly used in the treatment of cancer, although it can also be used in the treatment of some rare, non-cancerous diseases.Find more statistics on other topics about Germany with key insights such as number of hospitals and number of practicing midwives.

Radiation Therapy QA Systems Market Outlook

The global market size for Radiation Therapy QA Systems was valued at approximately USD 1.2 billion in 2023 and is projected to reach USD 2.3 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period. This growth is driven by the increasing incidence of cancer worldwide, advancements in radiation therapy technologies, and the rising adoption of quality assurance systems to ensure accurate and effective treatment.

One of the primary growth factors for the Radiation Therapy QA Systems market is the escalating prevalence of cancer, which is prompting healthcare providers to adopt advanced treatment modalities. The growing awareness among patients and healthcare professionals about the importance of early cancer diagnosis and treatment is also contributing to the market expansion. Furthermore, technological advancements in radiation therapy equipment, such as the development of more precise and effective radiation delivery systems, are driving the demand for QA systems to ensure these technologies are functioning correctly and safely.

Another significant growth driver is the increasing investment in healthcare infrastructure, particularly in emerging economies. Governments and private sector players are investing heavily in modernizing healthcare facilities, which includes the adoption of advanced radiation therapy equipment and QA systems. This trend is particularly evident in countries with rapidly growing healthcare sectors, such as China and India. These investments are expected to continue, thereby boosting the market for radiation therapy QA systems.

The rising focus on research and development activities in the field of radiation therapy is also fostering market growth. Research institutes and academic organizations are increasingly engaging in studies aimed at improving the efficacy and safety of radiation therapy. This has led to the development of new QA systems that are more sophisticated and capable of ensuring higher precision in treatment delivery. Additionally, collaborations between research organizations and medical device manufacturers are leading to the introduction of innovative QA solutions in the market.

From a regional perspective, North America holds a significant share of the Radiation Therapy QA Systems market, primarily due to the well-established healthcare infrastructure and the high adoption rate of advanced medical technologies. The Asia Pacific region is expected to witness the fastest growth during the forecast period, driven by the increasing healthcare expenditure, rising awareness about cancer treatment, and the rapid development of healthcare facilities. Europe and Latin America are also anticipated to experience steady growth, supported by the growing demand for advanced cancer treatment options.

Product Type Analysis

When analyzing the Radiation Therapy QA Systems market by product type, it is essential to consider both software and hardware components. The software segment is gaining significant traction due to its ability to provide precise data analytics and real-time monitoring of radiation therapy equipment. Advanced software solutions are designed to ensure that the radiation dose delivered to patients is accurate and conforms to the prescribed treatment plans. These software systems are equipped with features such as automated data collection, dose calculation, and error detection, which enhance the overall efficiency and safety of radiation therapy.

On the other hand, the hardware segment includes various devices and instruments used for quality assurance in radiation therapy. These include dosimeters, phantoms, and detectors, which are essential for measuring radiation dose and ensuring that the equipment is functioning correctly. The demand for these hardware components is driven by the need for precise and reliable measurements to ensure patient safety. The increasing installation of advanced radiation therapy equipment in healthcare facilities is further boosting the demand for QA hardware components.

The integration of software and hardware components in QA systems is a growing trend in the market. Hybrid systems that combine the capabilities of both segments are becoming increasingly popular as they offer a comprehensive solution for radiation therapy quality assurance. These integrated systems provide seamless data exchange between software and hardware components, enabling more accurate and efficient QA processes. This trend is expected to drive the growth of both software and hardware se

In 2024, Market Research Intellect valued the Radiation Therapy Software Market Report at USD 1.5 billion, with expectations to reach USD 3.2 billion by 2033 at a CAGR of 9.5%.Understand drivers of market demand, strategic innovations, and the role of top competitors.

The Intraoperative Radiation Therapy Report is Segmented by Method (Electron IORT, Intraoperative Brachytherapy, Other Methods), Products and Services (Products and Services), Application (Breast Cancer, Brain Tumor, and More), End User (Hospitals, Specialty Clinics, Others), and Geography (North America, and More). The Market Forecasts are Provided in Terms of Value (USD).

SRT provides targeted delivery of strong radiation beams to tumors which preserves nearby healthy tissue so medical professionals prefer this treatment for localized cancers found in brain tissue as well as lung tissue spine tissue and liver tissue. The forecast shows SRT market reaching USD 9,076 million by 2035 from its initial value of USD 4,570.8 million in 2025 which creates a 7.1% Compound Annual Growth Rate (CAGR).

Key Market Metrics

Metric	Value
Industry Size (2025E)	USD 4,570.8 million
Industry Value (2035F)	USD 9,076 million
CAGR (2025 to 2035)	7.1%

Country-Wise Outlook

Country	CAGR (2025 to 2035)
USA	7.0%

Country	CAGR (2025 to 2035)
UK	6.9%

Region	CAGR (2025 to 2035)
European Union	7.1%

Country	CAGR (2025 to 2035)
Japan	7.0%

Country	CAGR (2025 to 2035)
South Korea	7.5%

Segmentation Outlook

Technology Type	Market Share (2025)
CyberKnife	38.4%

Indication Type	Market Share (2025)
Lung Cancer	42.1%

Competitive Outlook

Company Name	Estimated Market Share (%)
Elekta AB	28-32%
Varian Medical Systems (Siemens Healthineers)	24-28%
Accuray Incorporated	14-18%
Brainlab AG	9-13%
ViewRay, Inc.	6-10%
Other Companies (combined)	12-17%

In 2021, the number of radiation therapy units in Austria did not change in comparison to the previous year. The number of radiation therapy units remained at 51 radiation therapy units. Radiation therapy equipment describes machines used for treatment with x-rays or radionuclide. By and large, this includes linear accelerators, Cobalt-60 units, Caesium-137 therapy units, low to orthovoltage x-ray units, high dose and low dose rate brachytherapy units and conventional brachytherapy units. Radiation therapy (or radiotherapy) is mostly used in the treatment of cancer, although it can also be used in the treatment of some rare, non-cancerous diseases.Find more statistics on other topics about Austria with key insights such as number of publicly owned hospitals and number of magnetic resonance imaging (MRI) scanners.

Snapshot img

Radiation Oncology Market Size 2024-2028

The radiation oncology market size is forecast to increase by USD 1.94 billion at a CAGR of4.34% between 2023 and 2028.

In the market, the primary drivers include the increasing incidence of cancer and the rise in healthcare expenditure. As cancer continues to be a significant health concern, the demand for advanced radiation therapy techniques, such as seeds and stereotactic therapy, is increasing. These treatments offer therapeutic benefits by targeting abnormal cells with precision, reducing the impact on healthy cells. Technological developments, including advanced treatment planning software, tumor tracking systems, artificial intelligence, and machine learning, enable more effective and personalized treatment plans. However, challenges persist, including the lack of access to radiotherapy in certain regions and the high cost of these advanced treatments. Despite these challenges, the market is expected to grow, driven by the potential for improved patient outcomes and the ongoing technological advancements In the field.

What will be the Size of the Radiation Oncology Market During the Forecast Period?

Request Free Sample

The market is a significant segment of the healthcare industry, focusing on the delivery of radiation therapy to treat various types of cancer. This form of oncology treatment, also known as radiotherapy, utilizes high-energy radiation to destroy tumor cells. Radiation oncology plays a crucial role in cancer treatment, with breast cancer, metastatic melanoma, and neuroendocrine cancers being some of the common indications. The increasing prevalence of cancer and the growing demand for advanced therapeutic benefits have driven the market's growth. Regulatory scrutiny remains a critical factor In the market.



Stringent regulations ensure the safety and efficacy of radiotherapy devices and treatment planning software. These regulations also apply to advanced technologies like proton therapy, which offers improved therapeutic benefits for certain types of cancer. Imaging data plays a pivotal role in radiation oncology. Accurate and timely access to imaging data is essential for effective treatment planning and delivery. Cancer treatment centers and oncology research institutes are investing in advanced imaging technologies to enhance their capabilities. Technological developments in radiation oncology are continually evolving. Companies are focusing on improving the precision, efficiency, and patient experience of radiotherapy. Radiotherapy devices, such as those manufactured by Elekta and Gamma Knife, are being enhanced with innovative features.

How is this Radiation Oncology Industry segmented and which is the largest segment?

The radiation oncology industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Type

  EBRT
  Brachytherapy


Application

  Breast cancer
  Lung cancer
  Penile cancer
  Prostate cancer
  Others


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  Asia

    China


  Rest of World (ROW)

By Type Insights

The EBRT segment is estimated to witness significant growth during the forecast period.

Radiation oncology, a specialized medical field focusing on the use of radiation to treat various types of cancer, encompasses external beam radiation therapy (EBRT). EBRT utilizes high-energy beams, typically generated by a Linear Accelerator (LINAC, the most common technology), to target and destroy cancer cells. These beams can be delivered as X-rays, electrons, or other particles, such as protons. EBRT plays a crucial role in treating numerous cancer types, including breast cancer, colorectal cancer (CRC), cervical cancer, esophageal cancer, head and neck cancer, lung cancer, prostate cancer, and brain tumors. Advanced radiotherapy systems, such as CyberKnife, Gamma Knife, and TomoTherapy, are also part of the EBRT market.

Furthermore, proton therapy, which uses cyclotrons and synchrotrons, is another subset of EBRT. Among these technologies, LINAC holds the largest market share In the market. By providing precise and effective cancer treatment, these advanced technologies contribute significantly to cancer treatment centers across the US and North America, ensuring improved patient outcomes and quality of life.

Get a glance at the Radiation Oncology Industry report of share of various segments Request Free Sample

The EBRT segment was valued at USD 6.22 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

Europe is estimated to contribute 39% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and driv

Radiation Therapy Software Market Outlook

The global radiation therapy software market size is projected to grow from USD 1.7 billion in 2023 to an estimated USD 3.5 billion by 2032, reflecting a compound annual growth rate (CAGR) of approximately 8.3%. The primary growth factors driving this market include the increasing prevalence of cancer, advancements in radiation therapy technologies, and the rising demand for more precise and efficient cancer treatment solutions. Additionally, the integration of artificial intelligence and machine learning into radiation therapy software is expected to further propel market growth during the forecast period.

One of the key drivers of growth in the radiation therapy software market is the rising incidence of cancer worldwide. According to the World Health Organization (WHO), cancer is one of the leading causes of death globally, with approximately 9.6 million deaths in 2018. This alarming statistic has led to an increased focus on improving cancer treatment methods, including radiation therapy. The need for more accurate and effective treatment planning and delivery has spurred the development and adoption of advanced radiation therapy software solutions. These systems enable healthcare providers to tailor treatment plans to individual patients, improving outcomes and reducing side effects.

Another significant growth factor is the continuous technological advancements in radiation therapy. Innovations such as image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), and volumetric modulated arc therapy (VMAT) have revolutionized the field of radiation oncology. These cutting-edge technologies require sophisticated software for treatment planning, dose management, and patient positioning. As a result, the demand for advanced radiation therapy software has surged, driving market growth. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in these software solutions is expected to enhance their capabilities, leading to more precise and efficient treatment planning and delivery.

The growing adoption of cloud-based solutions in the healthcare sector is another significant factor contributing to the market's expansion. Cloud-based radiation therapy software offers numerous advantages over traditional on-premises systems, including cost savings, scalability, and ease of access. These benefits have led to an increasing number of healthcare providers opting for cloud-based solutions. Additionally, the COVID-19 pandemic has accelerated the adoption of telehealth and remote monitoring solutions, further boosting the demand for cloud-based radiation therapy software. This trend is expected to continue in the coming years, driving market growth.

Regionally, North America holds the largest share of the radiation therapy software market, followed by Europe and Asia Pacific. The high prevalence of cancer, advanced healthcare infrastructure, and significant investments in research and development contribute to the dominance of North America. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period, driven by increasing healthcare expenditure, rising awareness about cancer treatment, and the growing adoption of advanced radiation therapy technologies. Emerging markets in Latin America and the Middle East & Africa are also expected to experience steady growth, supported by improving healthcare infrastructure and increasing focus on cancer treatment.

Product Type Analysis

The radiation therapy software market is segmented by product types, including Treatment Planning Systems, Dose Management Systems, Patient Positioning Systems, Image-Guided Radiation Therapy Systems, and Others. Each of these product types plays a crucial role in ensuring the precision and effectiveness of radiation therapy. Treatment Planning Systems are integral for devising customized treatment plans tailored to the specific needs of patients. This segment is expected to hold a significant market share, driven by the increasing demand for personalized treatment options and advancements in treatment planning algorithms. Additionally, the integration of AI and ML in treatment planning systems is anticipated to enhance their accuracy and efficiency, further propelling market growth.

Dose Management Systems are another critical component of radiation therapy software, ensuring that the prescribed dose of radiation is accurately delivered to the target area while minimizing exposure to surrounding healthy tissues. This segment is expected to witness substanti

The global radiation therapy market is anticipated to expand significantly over the forecast period, driven by factors such as the rising incidence of cancer, technological advancements, and increasing healthcare spending. In 2025, the market size stood at XXX million and is projected to reach XXX million by 2033, exhibiting a CAGR of XX% during the forecast period. Key market drivers include the growing adoption of advanced radiation therapy techniques, such as intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), rising demand for non-invasive and precise cancer treatments, and increasing government initiatives and investments in cancer research. Among the various segments, the external radiation therapy segment is expected to dominate the market throughout the forecast period. External radiation therapy involves delivering radiation beams from outside the body to target cancerous tissues. This technique offers advantages such as non-invasiveness, precision, and the ability to treat large areas of the body effectively. Furthermore, advancements in external radiation therapy, such as volumetric modulated arc therapy (VMAT) and stereotactic body radiation therapy (SBRT), are driving the growth of this segment. Geographically, North America and Europe are anticipated to hold significant market shares due to high healthcare spending, advanced healthcare infrastructure, and the presence of leading companies in these regions. However, Asia-Pacific is expected to witness the fastest growth rate during the forecast period, attributed to the rising burden of cancer and expanding healthcare infrastructure in the region. Radiation therapy is a cancer treatment that uses high-energy radiation to kill cancer cells. It is a common treatment for many types of cancer, including prostate, breast, and cervical cancer. Radiation therapy can be delivered externally, using a machine that directs radiation beams at the tumor, or internally, using radioactive implants that are placed directly into the tumor.

Radiation Therapy Equipment Market size was valued at USD 3.6 Billion in 2024 and is projected to reach USD 5.93 Billion by 2032, growing at a CAGR of 7.10% from 2026 to 2032.

Key Market Drivers:

Rising Cancer Incidence: The global incidence of cancer is a major driver of the Radiation Therapy Equipment Market. As cancer rates rise, there is a greater demand for advanced treatment alternatives such as radiation therapy, which pushes the use of radiation therapy equipment.

Technological Advancements: Continuous innovations in radiation therapy technologies, including as intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and proton therapy, are key drivers.

Global Global Radiation Oncology Market size worth at USD 21.16 Billion in 2023 and projected to USD 43.74 Billion by 2032, with a CAGR of around 8.4% between 2024-2032.

Intraoperative Radiation Therapy Systems Market size was worth $60.12 M in 2023, and is projected to hit $116.14 M by 2032, at a CAGR of 7.59%.

The global medical radiation therapy device market is experiencing steady growth, projected to reach a market size of $15 billion in 2025, exhibiting a Compound Annual Growth Rate (CAGR) of 5% from 2025 to 2033. This growth is fueled by several key drivers, including the rising prevalence of cancer globally, advancements in radiation therapy technologies like proton therapy and intensity-modulated radiation therapy (IMRT), and increasing demand for minimally invasive treatment options. Technological innovations leading to improved treatment accuracy, reduced side effects, and enhanced patient outcomes are significantly impacting market expansion. Furthermore, the aging global population and increased healthcare spending contribute to the market's positive trajectory. However, certain restraints challenge market growth. High costs associated with radiation therapy equipment and treatment, stringent regulatory approvals for new devices, and a shortage of skilled professionals specializing in radiation oncology pose obstacles. Despite these challenges, the market is expected to witness continued expansion driven by ongoing research and development in radiation therapy technology, along with the emergence of new treatment modalities. The market segmentation, encompassing various devices like linear accelerators, brachytherapy systems, and simulation systems, demonstrates significant diversity in the types of equipment contributing to overall market size and growth. This segmentation reflects the market's evolution and diversification in treatment approaches. Leading companies like Elekta, Varian Medical Systems, and Brainlab are major players shaping innovation and competition within this dynamic sector.

Radiotherapy Market size valued at US$ 7.14 Billion in 2023, set to reach US$ 11.41 Billion by 2032 at a CAGR of about 4.8% from 2024 to 2032.

This collection includes data from 211 patients who presented with head and neck cancer and were treated using radiation therapy at a single institution using 6 MV Intensity Modulated Radiation Therapy (IMRT) from a linear accelerator. All patients were prescribed identical prescriptions of 70 Gray (Gy) in 33 fractions for the primary planning target volume (PTV) and one, none, or a combination of integrated boost sub targets (PTV 54 Gy, PTV 56 Gy, PTV 57 Gy, PTV 60 Gy, PTV 63 Gy, PTV 66 Gy). The data for each patient contains the minimum required information for radiation treatment planning. Each patient set contains the planning computed tomography (CT) image set from treatment simulation, the expert-defined radiotherapy structure set (RTSTRUCT), the delivered radiotherapy plan file (RTPLAN), and the calculated treatment dose (RTDOSE). All files are provided in DICOM format.

CT Images: Planning CT images from treatment simulation and radiation dose calculation are included for each patient. Thermoplastic head and neck masks were used during image acquisition to achieve immobilization and ensure accurate and reproducible positioning during treatment. All images satisfied the resolution requirements for dose calculations and have an identical slice thicknesses of 2.5 mm. The provided CT files are those that match with the RTDOSE and RTSTRUCT files of the same patient.

Target and Organ Contours: Each patient’s data contains an RTSTRUCT DICOM with manually defined target volume contours and organ at risk (OAR) contours. For efficient OAR extraction from the RTSTRUCT files, we renamed all OAR contours that could be identified to a uniform structure name. If a contour was not identified, it was not defined for treatment, or the nomenclature was ambiguous. All planning target volumes (PTV) are included in the structure set. Due to inconsistent documentation and naming conventions, the primary PTV is difficult to distinguish from other PTV structures. For example, some patients include multiple iterations of the same contour as a result of modifications during treatment planning our assisted planning methods from the TPS. In addition to organ and target structures, we chose to leave in planning structures created and used by the dosimetrists for generating the plan. For example, PTV expansions, ring structures, avoidance structures, and normal tissue volumes were left within the RTSTRUCT file. OAR contours for 26 unique normal tissue structures were renamed to the ‘Standardized Name’ in the RTSTRUCT DICOM file. If a structure was not identified, the structure was not created in the original structure set.

Radiotherapy Dose and Treatment Plan: Each dose was planned by a dosimetrist and approved for treatment by the physician. Treatment plans were created using Pinnacle (Phillips Medical Systems, Fitchburg, WI). The dose was calculated on a 3 mm3 dose grid and plans were optimized for treatment on Elekta or Varian linear accelerators.

Research for challenging tumor sites like head and neck cancers can benefit from publicly accessible radiotherapy treatment datasets such as the one offered here. In particular, this dataset provides consistent treatment plans with limited variance due to the uniformity in tumor site, consistent institutional standards, and identical prescriptions. In artificial intelligence research, the need for large and uniform datasets is crucial for testing and evaluating the performance of novel architectures. Treatments of a single site from a single institution and with identical prescriptions will have reduced variance of tumor coverage and normal tissue-sparing objectives in comparison to multi-site and multi-institutional studies. However, it can also be combined with other radiotherapy treatment datasets for use in more generalized studies.